Lovastatin

Product NDC
63629-1020
11-digit product format
636291020
Labeler code
63629
Product ID
63629-1020_c18af9e7-b364-4f53-bd54-13b15797c7b5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lovastatin
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075991
Marketing category
ANDA
Marketing start
2002-11-25
Marketing end
0000-00-00
Substance
LOVASTATIN
Active strength
40 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63629-1020-02020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-12020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-22020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-32020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-52020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-62020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-82020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-02020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-12020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-22020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-32020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-52020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-62020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1020-82020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-1020-0636291020001000 TABLET in 1 BOTTLE (63629-1020-0) 1000 tablet2019-05-310000-00-00NoNoCurrent
63629-1020-163629102001100 TABLET in 1 BOTTLE (63629-1020-1) 100 tablet2019-05-310000-00-00NoNoCurrent
63629-1020-26362910200230 TABLET in 1 BOTTLE (63629-1020-2) 30 tablet2019-05-310000-00-00NoNoCurrent
63629-1020-363629102003300 TABLET in 1 BOTTLE (63629-1020-3) 300 tablet2019-05-310000-00-00NoNoCurrent
63629-1020-563629102005500 TABLET in 1 BOTTLE (63629-1020-5) 500 tablet2019-05-310000-00-00NoNoCurrent
63629-1020-66362910200660 TABLET in 1 BOTTLE (63629-1020-6) 60 tablet2019-05-310000-00-00NoNoCurrent
63629-1020-863629102008800 TABLET in 1 BOTTLE (63629-1020-8) 800 tablet2019-05-310000-00-00NoNoCurrent